Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or others by hourly observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders.
Read More…
Industry, Sector and Symbol
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryHealth Care Facilities
SectorMedical
Phone615-861-6000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.01 billion
Profitability
Miscellaneous
Employees42,100
Next Earnings Date11/4/2019 (Estimated)
OptionableOptionable
Acadia Healthcare (NASDAQ:ACHC) Frequently Asked Questions
What is Acadia Healthcare's stock symbol?
Acadia Healthcare trades on the NASDAQ under the ticker symbol "ACHC."
How were Acadia Healthcare's earnings last quarter?
Acadia Healthcare Company Inc (NASDAQ:ACHC) announced its quarterly earnings data on Tuesday, July, 30th. The company reported $0.61 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.59 by $0.02. The firm had revenue of $789 million for the quarter, compared to the consensus estimate of $795.31 million. Acadia Healthcare had a negative net margin of 6.80% and a positive return on equity of 7.20%. The company's revenue was up 3.0% on a year-over-year basis. During the same period last year, the firm earned $0.70 EPS. View Acadia Healthcare's Earnings History.
When is Acadia Healthcare's next earnings date?
What guidance has Acadia Healthcare issued on next quarter's earnings?
Acadia Healthcare updated its FY19 earnings guidance on Tuesday, July, 30th. The company provided earnings per share (EPS) guidance of $2.15-2.23 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.18. The company issued revenue guidance of $3.15-3.175 billion, compared to the consensus revenue estimate of $3.16 billion.
What price target have analysts set for ACHC?
10 brokerages have issued 1-year price objectives for Acadia Healthcare's stock. Their predictions range from $30.00 to $45.00. On average, they anticipate Acadia Healthcare's stock price to reach $37.11 in the next twelve months. This suggests a possible upside of 25.3% from the stock's current price. View Analyst Price Targets for Acadia Healthcare.
What is the consensus analysts' recommendation for Acadia Healthcare?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acadia Healthcare in the last year. There are currently 7 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Acadia Healthcare.
What are Wall Street analysts saying about Acadia Healthcare stock?
Here are some recent quotes from research analysts about Acadia Healthcare stock:
- 1. According to Zacks Investment Research, "Acadia Healthcare’s earnings of 61 cents per share beat the Zacks Consensus Estimate by 3.39% but were down 13% year over year. Earnings reflected rise in revenues, which was more than offset by a higher increase in expenses. Its shares have outperformed its industry, year to date. The company’s top line has been improving on the back of organic and inorganic growth initiatives. It has been actively emphasizing on acquisitions for expedited growth. Moreover, it is well poised to fund new bed development, given its impressive balance sheet, which has been generating increasing cash from operations over the years. It is in the process of adding approximately 700 new beds to existing and new facilities in 2019, which in turn will aid the top line. However, rising expenses, high labor cost, soft U.K business are concerns." (8/7/2019)
- 2. Cantor Fitzgerald analysts commented, "We rate ACHC Neutral primarily to reflect our view of the uncertainty associated with the recovery of its U.K. business, which accounts for 40% of the company’s revenue. $39 price target is based on comparable-company analysis and our DCF. The Disclosure Section may be found on pages 3 – 4.Valuation Our $39 price target reflects our reservations about the company’s ability to grow both organically and through acquisitions." (11/16/2018)
Has Acadia Healthcare been receiving favorable news coverage?
News coverage about ACHC stock has trended negative this week, InfoTrie reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Acadia Healthcare earned a coverage optimism score of -2.6 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Acadia Healthcare.
Are investors shorting Acadia Healthcare?
Acadia Healthcare saw a drop in short interest during the month of September. As of September 15th, there was short interest totalling 12,520,000 shares, a drop of 12.3% from the August 15th total of 14,270,000 shares. Based on an average daily volume of 763,400 shares, the days-to-cover ratio is currently 16.4 days. Currently, 14.5% of the company's stock are sold short. View Acadia Healthcare's Current Options Chain.
Who are some of Acadia Healthcare's key competitors?
What other stocks do shareholders of Acadia Healthcare own?
Who are Acadia Healthcare's key executives?
Acadia Healthcare's management team includes the folowing people:
- Mr. David M. Duckworth, CFO, Chief Accounting Officer & Controller (Age 39)
- Mr. Ronald Morgon Fincher, Chief Operating Officer (Age 66)
- Mr. Christopher L. Howard, Exec. VP, Gen. Counsel & Sec. (Age 52)
- Ms. Debra K. Osteen, CEO & Director (Age 63)
- Gretchen Hommrich, Director of Investor Relations
Who are Acadia Healthcare's major shareholders?
Acadia Healthcare's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Skyline Asset Management LP (0.25%), Pacer Advisors Inc. (0.04%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Acadia Healthcare stock include Debra K Osteen, Randall P Goldberg and Reeve B Waud. View Institutional Ownership Trends for Acadia Healthcare.
Which institutional investors are selling Acadia Healthcare stock?
Which institutional investors are buying Acadia Healthcare stock?
How do I buy shares of Acadia Healthcare?
Shares of ACHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Acadia Healthcare's stock price today?
One share of ACHC stock can currently be purchased for approximately $29.61.
How big of a company is Acadia Healthcare?
Acadia Healthcare has a market capitalization of $2.62 billion and generates $3.01 billion in revenue each year. The company earns $-175,750,000.00 in net income (profit) each year or $2.24 on an earnings per share basis. Acadia Healthcare employs 42,100 workers across the globe.View Additional Information About Acadia Healthcare.
What is Acadia Healthcare's official website?
How can I contact Acadia Healthcare?
Acadia Healthcare's mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The company can be reached via phone at 615-861-6000.
MarketBeat Community Rating for Acadia Healthcare (NASDAQ ACHC)
MarketBeat's community ratings are surveys of what our community members think about Acadia Healthcare and other stocks. Vote "Outperform" if you believe ACHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
